Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Identify the medical therapy options for IBD.
• Understand the mechanism of action of the various medical therapies for IBD.
• Appropriately prescribe medical therapies which includes biologics and other targeted therapies for IBD.
• Review microbiology, epidemiology, diagnosis and treatment of Clostridioides difficile infection.
• Compare, contrast, and comment on American College of Gastroenterology (ACG) and Infectious Diseases Society of America (IDSDA)/Society for Healthcare Epidemiology of America (SHEA) guidelines.
• Present best practices for prevention of Clostridioides difficile infection.
• Recognize the indications for liver transplantation.
• Appreciate the steps involved in evaluating candidates for liver transplant.
• Analyze liver transplant outcomes and complications.
• Recall the commonly used immunosuppressive medications.
• Recognize potential drug-drug interactions and other side effects of immunosuppressive medications.
• Provide an updated definition of irritable bowel syndrome.
• List factors that contribute to the pathogenesis of IBS symptoms.
• Develop a treatment strategy for the main IBS sub-types.
• List the most important unanswered questions about IBS.

Symposium Director

Kenneth Rosenthal, M.D., FACG
Gastroenterologist
Co-Chair BRRH CME Committee Chair
Boca Raton Regional Hospital
Baptist Health South Florida

Who Should Attend

Gastroenterologists, Radiologists, General Practitioners, Internal Medicine Physicians, Surgeons, Psychiatrists, Residents, Nurses, Nurse Practitioners, Dietitians, Clinical Pharmacists, Physician Assistants, and all other interested healthcare professionals.